Global Cyclophosphamide Market Professional Survey Report 2017

Publisher Name :
Date: 04-Dec-2017
No. of pages: 119
Inquire Before Buying

This report studies Cyclophosphamide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Baxter

- Roxane

- GLS Pharma Ltd

- Sanofi

- CSC PHARMACEUTICALS INTERNATIONAL

- LGM Pharma

- Pfizer

- Merck

- Allergan

- The Medicines Company

- Theravance Biopharma

- Basilea Pharmaceutica

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Cyclophosphamide Powder

- Cyclophosphamide Injection

By Application, the market can be split into

- Cancer

- Autoimmune Diseases

- AL Amyloidosis

- Other

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Cyclophosphamide Market Professional Survey Report 2017

Table of Contents
Global Cyclophosphamide Market Professional Survey Report 2017
1 Industry Overview of Cyclophosphamide
1.1 Definition and Specifications of Cyclophosphamide
1.1.1 Definition of Cyclophosphamide
1.1.2 Specifications of Cyclophosphamide
1.2 Classification of Cyclophosphamide
1.2.1 Cyclophosphamide Powder
1.2.2 Cyclophosphamide Injection
1.3 Applications of Cyclophosphamide
1.3.1 Cancer
1.3.2 Autoimmune Diseases
1.3.3 AL Amyloidosis
1.3.4 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Cyclophosphamide
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cyclophosphamide
2.3 Manufacturing Process Analysis of Cyclophosphamide
2.4 Industry Chain Structure of Cyclophosphamide
3 Technical Data and Manufacturing Plants Analysis of Cyclophosphamide
3.1 Capacity and Commercial Production Date of Global Cyclophosphamide Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Cyclophosphamide Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Cyclophosphamide Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Cyclophosphamide Major Manufacturers in 2016
4 Global Cyclophosphamide Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Cyclophosphamide Capacity and Growth Rate Analysis
4.2.2 2016 Cyclophosphamide Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Cyclophosphamide Sales and Growth Rate Analysis
4.3.2 2016 Cyclophosphamide Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Cyclophosphamide Sales Price
4.4.2 2016 Cyclophosphamide Sales Price Analysis (Company Segment)
5 Cyclophosphamide Regional Market Analysis
5.1 North America Cyclophosphamide Market Analysis
5.1.1 North America Cyclophosphamide Market Overview
5.1.2 North America 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Cyclophosphamide Sales Price Analysis
5.1.4 North America 2016 Cyclophosphamide Market Share Analysis
5.2 China Cyclophosphamide Market Analysis
5.2.1 China Cyclophosphamide Market Overview
5.2.2 China 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Cyclophosphamide Sales Price Analysis
5.2.4 China 2016 Cyclophosphamide Market Share Analysis
5.3 Europe Cyclophosphamide Market Analysis
5.3.1 Europe Cyclophosphamide Market Overview
5.3.2 Europe 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Cyclophosphamide Sales Price Analysis
5.3.4 Europe 2016 Cyclophosphamide Market Share Analysis
5.4 Southeast Asia Cyclophosphamide Market Analysis
5.4.1 Southeast Asia Cyclophosphamide Market Overview
5.4.2 Southeast Asia 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Cyclophosphamide Sales Price Analysis
5.4.4 Southeast Asia 2016 Cyclophosphamide Market Share Analysis
5.5 Japan Cyclophosphamide Market Analysis
5.5.1 Japan Cyclophosphamide Market Overview
5.5.2 Japan 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Cyclophosphamide Sales Price Analysis
5.5.4 Japan 2016 Cyclophosphamide Market Share Analysis
5.6 India Cyclophosphamide Market Analysis
5.6.1 India Cyclophosphamide Market Overview
5.6.2 India 2012-2017E Cyclophosphamide Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Cyclophosphamide Sales Price Analysis
5.6.4 India 2016 Cyclophosphamide Market Share Analysis
6 Global 2012-2017E Cyclophosphamide Segment Market Analysis (by Type)
6.1 Global 2012-2017E Cyclophosphamide Sales by Type
6.2 Different Types of Cyclophosphamide Product Interview Price Analysis
6.3 Different Types of Cyclophosphamide Product Driving Factors Analysis
6.3.1 Cyclophosphamide Powder of Cyclophosphamide Growth Driving Factor Analysis
6.3.2 Cyclophosphamide Injection of Cyclophosphamide Growth Driving Factor Analysis
7 Global 2012-2017E Cyclophosphamide Segment Market Analysis (by Application)
7.1 Global 2012-2017E Cyclophosphamide Consumption by Application
7.2 Different Application of Cyclophosphamide Product Interview Price Analysis
7.3 Different Application of Cyclophosphamide Product Driving Factors Analysis
7.3.1 Cancer of Cyclophosphamide Growth Driving Factor Analysis
7.3.2 Autoimmune Diseases of Cyclophosphamide Growth Driving Factor Analysis
7.3.3 AL Amyloidosis of Cyclophosphamide Growth Driving Factor Analysis
7.3.4 Other of Cyclophosphamide Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Cyclophosphamide
8.1 Baxter
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Baxter 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Baxter 2016 Cyclophosphamide Business Region Distribution Analysis
8.2 Roxane
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Roxane 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Roxane 2016 Cyclophosphamide Business Region Distribution Analysis
8.3 GLS Pharma Ltd
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 GLS Pharma Ltd 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 GLS Pharma Ltd 2016 Cyclophosphamide Business Region Distribution Analysis
8.4 Sanofi
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Sanofi 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi 2016 Cyclophosphamide Business Region Distribution Analysis
8.5 CSC PHARMACEUTICALS INTERNATIONAL
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 CSC PHARMACEUTICALS INTERNATIONAL 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 CSC PHARMACEUTICALS INTERNATIONAL 2016 Cyclophosphamide Business Region Distribution Analysis
8.6 LGM Pharma
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 LGM Pharma 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 LGM Pharma 2016 Cyclophosphamide Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Pfizer 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2016 Cyclophosphamide Business Region Distribution Analysis
8.8 Merck
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Merck 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Merck 2016 Cyclophosphamide Business Region Distribution Analysis
8.9 Allergan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Allergan 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Allergan 2016 Cyclophosphamide Business Region Distribution Analysis
8.10 The Medicines Company
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 The Medicines Company 2016 Cyclophosphamide Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 The Medicines Company 2016 Cyclophosphamide Business Region Distribution Analysis
8.11 Theravance Biopharma
8.12 Basilea Pharmaceutica
9 Development Trend of Analysis of Cyclophosphamide Market
9.1 Global Cyclophosphamide Market Trend Analysis
9.1.1 Global 2017-2022 Cyclophosphamide Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Cyclophosphamide Sales Price Forecast
9.2 Cyclophosphamide Regional Market Trend
9.2.1 North America 2017-2022 Cyclophosphamide Consumption Forecast
9.2.2 China 2017-2022 Cyclophosphamide Consumption Forecast
9.2.3 Europe 2017-2022 Cyclophosphamide Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Cyclophosphamide Consumption Forecast
9.2.5 Japan 2017-2022 Cyclophosphamide Consumption Forecast
9.2.6 India 2017-2022 Cyclophosphamide Consumption Forecast
9.3 Cyclophosphamide Market Trend (Product Type)
9.4 Cyclophosphamide Market Trend (Application)
10 Cyclophosphamide Marketing Type Analysis
10.1 Cyclophosphamide Regional Marketing Type Analysis
10.2 Cyclophosphamide International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Cyclophosphamide by Region
10.4 Cyclophosphamide Supply Chain Analysis
11 Consumers Analysis of Cyclophosphamide
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Cyclophosphamide Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Cyclophosphamide
Table Product Specifications of Cyclophosphamide
Table Classification of Cyclophosphamide
Figure Global Production Market Share of Cyclophosphamide by Type in 2016
Figure Cyclophosphamide Powder Picture
Table Major Manufacturers of Cyclophosphamide Powder
Figure Cyclophosphamide Injection Picture
Table Major Manufacturers of Cyclophosphamide Injection
Table Applications of Cyclophosphamide
Figure Global Consumption Volume Market Share of Cyclophosphamide by Application in 2016
Figure Cancer Examples
Table Major Consumers in Cancer
Figure Autoimmune Diseases Examples
Table Major Consumers in Autoimmune Diseases
Figure AL Amyloidosis Examples
Table Major Consumers in AL Amyloidosis
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Cyclophosphamide by Regions
Figure North America Cyclophosphamide Market Size (Million USD) (2012-2022)
Figure China Cyclophosphamide Market Size (Million USD) (2012-2022)
Figure Europe Cyclophosphamide Market Size (Million USD) (2012-2022)
Figure Southeast Asia Cyclophosphamide Market Size (Million USD) (2012-2022)
Figure Japan Cyclophosphamide Market Size (Million USD) (2012-2022)
Figure India Cyclophosphamide Market Size (Million USD) (2012-2022)
Table Cyclophosphamide Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cyclophosphamide in 2016
Figure Manufacturing Process Analysis of Cyclophosphamide
Figure Industry Chain Structure of Cyclophosphamide
Table Capacity and Commercial Production Date of Global Cyclophosphamide Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Cyclophosphamide Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Cyclophosphamide Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Cyclophosphamide Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Cyclophosphamide 2012-2017
Figure Global 2012-2017E Cyclophosphamide Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Cyclophosphamide Market Size (Value) and Growth Rate
Table 2012-2017E Global Cyclophosphamide Capacity and Growth Rate
Table 2016 Global Cyclophosphamide Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Cyclophosphamide Sales (K MT) and Growth Rate
Table 2016 Global Cyclophosphamide Sales (K MT) List (Company Segment)
Table 2012-2017E Global Cyclophosphamide Sales Price (USD/MT)
Table 2016 Global Cyclophosphamide Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure North America 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure North America 2016 Cyclophosphamide Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure China 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure China 2016 Cyclophosphamide Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure Europe 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure Europe 2016 Cyclophosphamide Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure Southeast Asia 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure Southeast Asia 2016 Cyclophosphamide Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure Japan 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure Japan 2016 Cyclophosphamide Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Cyclophosphamide 2012-2017E
Figure India 2012-2017E Cyclophosphamide Sales Price (USD/MT)
Figure India 2016 Cyclophosphamide Sales Market Share
Table Global 2012-2017E Cyclophosphamide Sales (K MT) by Type
Table Different Types Cyclophosphamide Product Interview Price
Table Global 2012-2017E Cyclophosphamide Sales (K MT) by Application
Table Different Application Cyclophosphamide Product Interview Price
Table Baxter Information List
Table Product A Overview
Table Product B Overview
Table 2016 Baxter Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Baxter Cyclophosphamide Business Region Distribution
Table Roxane Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roxane Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roxane Cyclophosphamide Business Region Distribution
Table GLS Pharma Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2015 GLS Pharma Ltd Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 GLS Pharma Ltd Cyclophosphamide Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sanofi Cyclophosphamide Business Region Distribution
Table CSC PHARMACEUTICALS INTERNATIONAL Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Business Region Distribution
Table LGM Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 LGM Pharma Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 LGM Pharma Cyclophosphamide Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Cyclophosphamide Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Merck Cyclophosphamide Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergan Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Allergan Cyclophosphamide Business Region Distribution
Table The Medicines Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 The Medicines Company Cyclophosphamide Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 The Medicines Company Cyclophosphamide Business Region Distribution
Table Theravance Biopharma Information List
Table Basilea Pharmaceutica Information List
Figure Global 2017-2022 Cyclophosphamide Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Cyclophosphamide Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Cyclophosphamide Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Cyclophosphamide Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Cyclophosphamide by Type 2017-2022
Table Global Consumption Volume (K MT) of Cyclophosphamide by Application 2017-2022
Table Traders or Distributors with Contact Information of Cyclophosphamide by Region
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs